483
Abbott VascularFDA 483 - Abbott Vascular - May 03, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Abbott Vascular in Menlo Park, CA, from April 26 to May 3, 2023, revealed significant deficiencies in their quality system. The firm's procedures for rework and continued processing of nonconforming product were found to be inadequate. Specifically, these procedures failed to include provisions for evaluating the adverse effects of such processes on the final product.
Open in Dashboard
ID · 5d54253a-6ece-4ab6-8317-6c616266e862